605199.SS
Hainan Huluwa Pharmaceutical Group Co., Ltd. [605199.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
605199.SS Stock Summary
Top 10 Correlated ETFs
605199.SS
Top 10 Correlated Stocks
605199.SS
In the News
605199.SS Financial details
Company Rating
-
Market Cap
4.67B
Income
91.3M
Revenue
1.74B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
2.08K
Optionable
No
Shortable
Yes
Earnings
29 Apr 2022
P/E
64.63
Forward P/E
-
PEG
24.86
P/S
3.35
P/B
5.41
P/C
-
P/FCF
-9.06
Quick Ratio
1.29
Current Ratio
1.82
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.23
EPS next Y
-
EPS next Q
-
EPS this Y
16.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-7.49%
Revenue last 5Y
9.02%
Revenue Q/Q
-5.88%
EPS Q/Q
-22.5%
-
-
-
-
SMA20
-10.95%
SMA50
-22.71%
SMA100
-10.77%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
9%
ROC
0.06%
Gross Margin
50%
Oper. Margin
7%
Profit Margin
5%
Payout
25%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.51-20.09
52W High
-37.95%
52W Low
+37.89%
RSI
31.54
Rel Volume
0.02
Avg Volume
3.08M
Volume
69.4K
Perf Week
-17.32%
Perf Month
-26.44%
Perf Quarter
-2.44%
Perf Half Y
-10.91%
-
-
-
-
Beta
0.658
-
-
Volatility
0.74%, 1.13%
Prev Close
-4.98%
Price
12.41
Change
-4.98%
Company Profile
- Volume Average 3.08M
- Market Capitalization 4.67B
- Employee 2.08K
- CEO Ms. Jinping Liu
- Headquarters Haikou,CN
- IPO Date 2020-07-10
-
Website
https://www.huluwayaoye.com 
Hainan Huluwa Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of drugs in the areas of Children's respiratory and digestive systems in China. Its primary products include 4 grams of pediatric lung heat cough granules and capsules. The company was founded in 2005 and is based in Haikou, China.
